Polymer-free sirolimus-eluting coronary stent designed for percutaneous coronary intervention (PCI) in patients with coronary artery disease. The Nano+ system delivers sirolimus to inhibit neointimal proliferation while eliminating polymer-related inflammation, reducing restenosis risk. Indicated fo...
Manufactured by
Lepu Medical (Europe) Inc. Coöperatief U.A
Heerenveen, Netherlands
Lepu Medical Technology (Beijing) Co., Ltd., established in 1999, is one of China's earliest enterprises engaged in the research and development of interventional cardiology medical devices. In 2009, Lepu Medical was successfully listed on the Shenzhen Stock Exchange s Growth Enterprise Market (Stock Code: 300003). In 2022, Lepu Medical was also listed on the Swiss Stock Exchange (ISIN: US52678P2056). Our two subsidiaries, LEPU BIOPHARMA and Scientech, are also listed on the Hong Kong Stock Exchange.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Kossel Medtech (Suzhou) Co., Ltd.
China · 3 relevant products
Shanghai Easy-Flow Medical Tech Co., Ltd
China · 5 relevant products
Relisys Medical Devices Ltd
India · 5 relevant products
55 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →9 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 107 closest product alternatives
Kossel Medtech (Suzhou) Co., Ltd. · China
MiStent® is a sirolimus-eluting coronary stent with absorbable polymer coating designed for percutaneous coronary intervention. The cobalt chromium alloy structure provides sustained radial support and fatigue resistance for treating coronary artery stenosis. The drug-eluting mechanism reduces neointimal proliferation while the absorbable polymer eliminates chronic inflammatory response after healing.
Shanghai Easy-Flow Medical Tech Co., Ltd · China
Peripheral drug-eluting stent for arterial disease treatment, delivering sirolimus to prevent restenosis in peripheral vasculature.
Relisys Medical Devices Ltd · India
A drug-eluting coronary stent system designed to treat coronary artery disease by delivering sirolimus to prevent restenosis. The stent is placed via percutaneous coronary intervention to restore blood flow in narrowed arteries.
104 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products